At the Precious Metals and Critical Minerals Virtual Investor Conference, First Phosphate Corp. (@FirstPhosphate) (@Nasdaq: PHOS) (CSE: $PHOS.CN ) (OTCQX: FRSPF) (FSE: KD0) Chief Executive Officer John Passalacqua walked investors through the company's Bégin-Lamarche deposit in the Saguenay-Lac-Saint-Jean region of Québec. The company is developing a high-purity igneous phosphate deposit for the lithium iron phosphate, LFP, battery industry. First Phosphate Corp. is a New and Notable company in the B2i Digital (@b2idigital) network. To learn more, visit firstphosphate.com The igneous anorthosite at Bégin-Lamarche, as Passalacqua described it, runs from the rock in the ground to purified phosphoric acid for the LFP battery industry: • Igneous phosphate rock accounts for only 5% of the world's phosphate deposits, he said, found mainly in Québec, Northern Russia, Southern Africa and Brazil • He described the Bégin-Lamarche anorthosite as very pure, with consistent mineralogy • He said solventless recovery takes out the ilmenite, magnetite and silicates and leaves a very pure phosphate, and that 91.1% of it can be converted directly into purified phosphoric acid for the LFP battery • By his description, the open-pit resource runs about 2.7 kilometres long and about 500 metres wide to a depth of about 400 metres, and remains open at depth Regarding the phosphate left after that recovery, Passalacqua stated: "We get to this phosphate reading of 40.4%, which is amongst the world's cleanest and highest purity phosphates out there." Watch the full presentation: youtube.com/watch?v=9m-d5k6q… First Phosphate Corp. (NASDAQ: PHOS) (CSE: PHOS) (OTCQX: FRSPF) (FSE: KD0) is a mineral exploration, development and clean technology company dedicated to building and reshoring a vertically integrated mine-to-market supply chain for the production of LFP batteries in North America. Target markets include energy storage, data centers, robotics, mobility, and national security. First Phosphate's flagship Bégin-Lamarche property, located in Saguenay-Lac-Saint-Jean, Québec, represents a rare North American igneous phosphate resource of high-purity phosphate characterized by very low levels of impurities. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.

Kolibri Global Energy Inc. (@KolibriEnergy) (@Nasdaq : $KGEI, TSX: KEI) is testing a new bench, the False Caney, in its Lovina well, and Wolf Regener, CEO and President, explained that test in his September 24, 2026 presentation at the Sidoti Small-Cap Virtual Investor Conference. The Lovina well location, being in a new bench, was not included in the company's December 31, 2025 reserve report. Kolibri Global Energy Inc. is a B2i Digital (@b2idigital) Featured Company. See the company's in-depth profile at: b2idigital.com/kolibri-globa… Kolibri's case for the False Caney rests on log and core data from its existing wells, and the Lovina lateral has been drilled: • Wells drilled to reach the Caney and the Woodford below it gave Kolibri logs through the False Caney, Caney, T zone and Sycamore, Regener explained • Kolibri's July 2026 corporate presentation identifies the False Caney bench as prospective on approximately 9,900 net acres • Per its September 21, 2026 release, Kolibri was anticipating beginning fracture stimulation of the 1.2-mile lateral early in the fourth quarter Regarding what the logs showed, @WolfRegener, CEO and President, stated: "But the False Caney, from all the logs, looks like it should be a productive interval. We have petrophysics even from a whole core, which showed excellent shale reservoir quality in the location that it was." Watch the full presentation (registration required): sidoti.zoom.us/webinar/regis… Kolibri Global Energy Inc. is a North American energy company focused on finding and exploiting energy projects in oil and gas. Through various subsidiaries, the Company owns and operates energy properties in the United States. The Company continues to utilize its technical and operational expertise to identify and acquire additional projects in oil and gas. The Company's shares are traded on the Toronto Stock Exchange under the stock symbol KEI and on the NASDAQ under the stock symbol KGEI. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted KGEI stock, in line with B2i Digital's practice of investing alongside its Featured Companies. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer.

Unicycive Therapeutics, Inc. (@unicycive) (@Nasdaq: $UNCY) has a Prescription Drug User Fee Act (PDUFA) target action date of March 25, 2027 for oxylanthanum carbonate (OLC), its investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis, now that the U.S. Food and Drug Administration (FDA) (@FDA) has accepted the company's New Drug Application (NDA) resubmission. The FDA has deemed the resubmission a Class II with a six-month review period from the resubmission date. Unicycive Therapeutics, Inc. is a B2i Digital (@b2idigital) Featured Company. See the company's in-depth profile at: b2idigital.com/unicycive-the… Under the 505(b)(2) regulatory pathway, the NDA for OLC is supported by clinical, preclinical and Chemistry, Manufacturing, and Controls (CMC) data: • Three clinical studies: a Phase 1 study in healthy volunteers, a bioequivalence study in healthy volunteers, and a tolerability study of OLC in CKD patients on dialysis • Multiple preclinical studies • The resubmission includes CMC data from a new third-party drug product manufacturing vendor Regarding the review, Shalabh Gupta, M.D., Chief Executive Officer of Unicycive, stated: "We hope to continue working with the FDA toward potential approval of this important medication to patients with CKD on dialysis who need additional treatment options for managing hyperphosphatemia." Read the full release: ir.unicycive.com/news/detail… Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit Unicycive.com and follow us on LinkedIn and X. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. David Shapiro (@davidshapiroNYC), Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted UNCY stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer.

Rocket Doctor AI Inc. (@rocketdoctor) (CSE: $AIDR.CN , OTC: AIRDF, Frankfurt: 939) announced that its wholly owned subsidiary, Rocket Doctor Inc., has been selected as a Finalist in the 8th Annual Digital Health & AI Awards, hosted by the Digital Health Hub Foundation (@DigiHlthHubFdn) at HLTH 2026 in Las Vegas. The recognition honors companies delivering remarkable innovation, measurable clinical impact, and transformation across the digital health and AI ecosystem. Rocket Doctor AI Inc. is a B2i Digital (@b2idigital) Featured Company. See the company's in-depth profile at: b2idigital.com/rocket-doctor… From a competitive field of over 1,800 submissions worldwide, Rocket Doctor was selected as a Finalist and will also be featured in "Innovations from Canada" at HLTH: • Selected as one of only five finalists in the "Best in Class" Track for Civic Health: Affordability, Access & Health Equity • Will participate in the "Innovations from Canada" Global Village on Monday, November 16, at HLTH, presenting a pitch • Will be prominently featured in the "Innovations from Canada" Pavilion, highlighting top Canadian digital health companies supported by the MaRS and D3 Accelerators The 8th Annual Digital Health & AI Awards Grand Finale will take place on November 16, 2026, at HLTH in Las Vegas, bringing together leaders, investors, health systems, and innovators from across the global healthcare ecosystem. "Being recognized as a finalist from among 1,800 global digital health innovators is a huge honor, and a strong validation of our mission," said Dr. William Cherniak, Founder & CEO of Rocket Doctor Inc. Read the full release: globenewswire.com/news-relea… Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide. Alongside the GLM is its digital health platform and marketplace which allows physicians to set up their own virtual practices and to date has helped more than 350 physicians support over 800,000 patient visits across U.S. and Canada. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer.

ZenaTech, Inc. (@ZenatechInc) (Nasdaq: $ZENA ) on October 20, 2026, outlined the capabilities and commercial strategy behind ZenaWorx, its drone-based construction monitoring software targeting AI data centers, infrastructure and public works projects. ZenaWorx was introduced in May 2026, and in August 2026 the Company announced its first paying customer for AI data center construction monitoring and the addition of beta-stage digital terrain modeling. ZenaTech, Inc. is a B2i Digital (@b2idigital) Featured Company. See the company's in-depth profile at: b2idigital.com/zenatech-1 ZenaWorx's planned capabilities and applications support the work of surveyors, engineers and construction managers by providing additional measured site information such as: • 3D construction progress monitoring: Creating digital site models that help teams review structural and site development over time • Digital terrain modeling: Representing ground elevations and surface conditions to support earthworks planning and monitoring • Cut-and-fill measurement: Measuring the volumes of material removed or added during site preparation ZenaWorx is being offered through ZenaTech’s Drone as a Service network. The service is designed to be subscription-based for repeat-service arrangements spanning the life of construction projects. Shaun Passley, Ph.D., CEO of ZenaTech, said: "With ZenaWorx, we are combining our Drone as a Service field locations network with drone data and software to give customers a consistent view of their projects from earthworks through structural development." Read the full release: zenatech.com/zenatech-detail… B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer.

Management presentations from the Precious Metals & Critical Minerals Virtual Investor Conference, held Tuesday, October 13 through Thursday, October 15, 2026, and hosted by Virtual Investor Conferences, are now available to watch on demand on the B2i Digital YouTube channel. Each recording carries the full session as management delivered it live, so anyone who missed a slot on the agenda can work through the companies at their own pace. The Precious Metals & Critical Minerals Virtual Investor Conference is a B2i Digital (@b2idigital ) Featured Conference. See event details and profiles of presenting companies at: b2idigital.com/oct-13th-15th… Investors researching precious metals and critical minerals can watch presentations from all three days, each posted as its own video: • Full-length recordings of management presentations delivered October 13 through 15, most of them running close to half an hour • Companies working across gold, silver, copper, rare earths, phosphate, uranium, platinum group metals, antimony, cobalt, nickel, mining royalties and streaming, and nuclear waste disposal • Presenting companies listed on Nasdaq, OTC Markets, the Toronto Stock Exchange, the TSX Venture Exchange, the Canadian Securities Exchange, Cboe Canada, the Australian Securities Exchange, the London Stock Exchange and the AQUIS Stock Exchange Watch the presentations: youtube.com/@b2idigital Presentations from Tuesday, October 13, 2026: NeoTerra Group Plc (@NeoTerraPLC) (OTCQB: ANRCF | LSE: TERA) Copper Intelligence Inc. (@CopperIntelCu29) (OTCID: CUAI) Arizona Eagle Mining Corp. (@AzEagleMining) (OTCQB: AZEMF | TSXV: AZEM) Lion Copper Corp. (@LionCopperGold) (OTCQB: LCGMF | CSE: LCU) ONGold Resources Ltd. (OTCQB: ONGRF | TSXV: ONAU) Viva Gold Corp. (@VivaGoldCorp) (OTCQB: VAUCF | TSXV: VAU) Bravada Gold Corp. (@BravadaGold) (OTCQB: BGAVF | TSXV: $BVA.V) First Phosphate Corp. (@FirstPhosphate) (OTCQX: FRSPF | CSE: PHOS | Nasdaq: $PHOS ) Canadian Phosphate Limited (@CanadianPhosLtd) (OTCQB: $CPHOF | ASX: CP8) Presentations from Wednesday, October 14, 2026: Royal Road Minerals Limited (OTCQB: RRDMF | TSXV: RYR) Atomic Eagle Ltd. (@AtomicEagleASX) (OTCQX: AEUXF | ASX: AEU) Japan Gold Corp. (@japangoldcorp) (OTCQB: JGLDF | TSXV: JG) Honey Badger Silver Inc. (@honeybadgertuf) (OTCQB: HBEIF | TSXV: TUF) Heliostar Metals Ltd. (@HeliostarMetals) (OTCQX: HSTXF | TSX: HSTR) Denarius Metals Corp. (@DenariusMetals) (OTCQX: DNRSF | Cboe Canada: DMET) Dryden Gold Corp. (@DrydenGold) (OTCQX: DRYGF | TSXV: DRY) Kootenay Silver Inc. (@KootenaySilver) (OTCQX: KOOYF | TSXV: KTN) Star Gold Corp. (@StarGoldCorp) (OTCQB: SRGZ) Silverco Mining Ltd. (@SilvercoMining) (OTCQB: SICOF | TSXV: SICO) Newcore Gold Ltd. (@NewcoreGold) (OTCQX: NCAUF | TSXV: NCAU) Deep Isolation Nuclear, Inc. (@DeepIsolation) (OTCQB: DBHL) Walhalla Gold Corp. (OTCQB: WAUXF | CSE: WAU) Presentations from Thursday, October 15, 2026: Novo Resources Corp. (OTCQB: NSRPF | TSX: NVO) Granada Gold Mine Inc. (@granadagold) (OTC: GBBFF | TSXV: GGM) American Rare Earths Ltd. (@ARRLimited) (OTCQX: ARRNF | ASX: ARR) Koryx Copper S.A. (@KoryxCopper) (OTCQX: KRYXF | TSXV: $KRY.V ) Gold Terra Resource Corp. (@GoldTerra) (OTCQB: YGTFF | TSXV: YGT) Evolve Royalties Ltd. (@EvolveRoyalties) (OTCQX: EVRYF | CSE: EVR) Eastport Critical Metals Corp. (OTCQB: EVIIF | TSXV: EVI) Stillwater Critical Minerals Corp. (@Stillwater_CM) (OTCQX: PGEZF | TSXV: PGE) Regency Silver Corp. (@regencysilverco) (OTCQB: RSMXF | TSXV: RSMX) Founders Metals Inc. (@FoundersMetals) (OTCQX: FDMIF | TSXV: FDR) Renforth Resources Inc. (@RenforthRes) (CSE: $RFR.CN | OTC: RFHRF) Majestic Corporation Plc (@majesticglobal) (OTCQB: MCJCF | AQUIS: MCJ) View all presentations on the event page: virtualinvestorconferences.c… B2i Digital, The Capital Markets Matchmaker℠, carries each presenting company's story From Marketing to Meetings℠, across its media network with a combined monthly audience of more than 330 million and its own community of 1.7 million+ investors and market participants. Virtual Investor Conferences is an @OTCMarkets Group Inc. property. Learn more at virtualinvestorconferences.c…. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.

Renforth Resources Inc. (@RenforthRes) (CSE: $RFR.CN | OTC: RFHRF) reported assay results for the two undercut drillholes at its wholly owned Parbec Gold Deposit in Malartic, Quebec, and each hole intersected gold above the cut-off grade used in the April 2025 Mineral Resource Estimate (MRE), within the open pit footprint of that estimate. Renforth Resources Inc. is a B2i Digital (@b2idigital) Featured Company. See the company's in-depth profile at: b2idigital.com/renforth-reso… Designed to test the area under this year's surface gold results, the program intersected gold mineralization under the stripped area and deeper in the Parbec open pit shell, in previously untested areas of the 2025 MRE deposit model, with lengths as measured in the core box and true widths not known: • 9.41 g/t Au over 4.05m in PAR-26-150, the highest grade-thickness result in the program, within the open pit shell • 15.68 g/t Au over 0.85m in PAR-26-149, the highest single sample result in the program, within the open pit shell • 1.45 g/t Au over 11.6m in PAR-26-150, including 2.40 g/t Au over 5.3m • 1.36 g/t Au over 11.0m in PAR-26-149, including 2.05 g/t Au over 6.5m Regarding the mineralized envelopes and multiple gold occurrences each hole encountered down the hole, Nicole Brewster, President and CEO of Renforth, stated: "Like the recent surface results, these drill intersections, which include both high and low grades and long widths, have intersected gold in parts of the deposit not previously tested by drilling." Read the full release: thenewswire.com/press-releas… The Parbec Mineral Resource Estimate (SGS Canada Inc., effective April 4, 2025) comprises a Measured and Indicated Mineral Resource of 265,800 ounces of gold and an additional Inferred Mineral Resource of 97,000 ounces of gold. Mineral resources are not mineral reserves and do not have demonstrated economic viability. Technical and exploration information in the release was reviewed and approved by Francis R. Newton, P. Geo. OGQ, an independent qualified person as defined by NI 43-101. Renforth Resources Inc. (CSE: RFR | OTC: RFHRF | FSE: 9RR) is a Canadian junior gold and critical minerals resource company focused on advancing the Parbec gold deposit in the prolific Abitibi region of Québec to the point where Renforth can monetize Parbec in order to develop Renforth's Victoria nickel focussed bulk tonnage polymetallic deposit. Parbec is strategically located immediately adjacent to Agnico Eagle Mines Limited's (TSX: AEM | NYSE: AEM) Canadian Malartic complex, one of the largest open-pit gold mines in Canada. Renforth's Victoria Ni/Cu/Co/Zn polymetallic deposit is also contiguous to Canadian Malartic, with a resource declared over only 12% of the ~20km length of the mineralized structure, forming part of a wholly owned district scale property with several mineralized occurrences. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer.

DataMeds AI, Inc. (@DataMEDSAI) (@Nasdaq : $MEDS ) has refocused the Helomics workforce toward commercializing ChemoFx® as a diagnostic lab test to help oncologists inform their chemotherapy regimen selection, initially for gynecologic cancers only. The update covers its CLIA lab Helomics, acquired September 11, 2026, and its Predictive Oncology division. DataMeds AI, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: b2idigital.com/datameds-ai-i… ChemoFx was recently included, for the first time, in a Humana Medicaid coverage policy for gynecologic cancers, and the update details the test and the company's oncology plans: • The ChemoFx Assay tests a patient's live tumor cells against a panel of chemotherapy agents to help inform treatment decisions in gynecologic cancers, is billed under CPT codes 81535 and 81536, and is a laboratory-developed test (LDT) that has not been cleared or approved by the U.S. Food and Drug Administration • Interim Co-CEO Gerald E. Commissiong (@G_Commish) said the company is preparing to relaunch a marketing campaign for ChemoFx and has begun discussions with hospital systems, HMOs, GPOs and cancer centers to add it to their cancer testing programs where appropriate • DataMeds AI plans to develop an oncology support module within the Health Lives Here app, now available on Android and iOS On the clinical evidence, Commissiong said: "A landmark 2015 peer-reviewed publication in PLOS reviewed evidence supporting the clinical utility and cost-effectiveness of using the ChemoFx Assay for chemotherapy regimen selection in epithelial ovarian cancer (EOC)." Read the full release: datamedsai.com/datameds-si-p… DataMeds AI, Inc. (DBA DataMeds SI) (Nasdaq: MEDS) is a healthcare company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its Health IT platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates the super intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into Tollo Health, LLC's Health Lives Here mobile application, and its Corexa Pharmacy provides pharmacy dispensing and related services, including the distribution of products developed by Tollo Health (@TolloHealth). The Company's Helomics Corporation subsidiary operates a CLIA-certified laboratory in Pittsburgh offering the ChemoFx® Assay. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer.